• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LTD. - HUNTINGTON ACRYSOF IQ TORIC SINGLEPIECE IOL; LENS, INTRAOCULAR, TORIC OPTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LTD. - HUNTINGTON ACRYSOF IQ TORIC SINGLEPIECE IOL; LENS, INTRAOCULAR, TORIC OPTICS Back to Search Results
Model Number SN6AT3
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problems Failure of Implant (1924); Visual Impairment (2138)
Event Date 03/19/2018
Event Type  Injury  
Manufacturer Narrative
Evaluation summary: the product was not returned.Product history records were reviewed and the documentation indicated the product met release criteria.A company representative reviewed the provided photos.Images show pseudophakic eyes (unable to identify the implanted iol models from the pictures).The image is focused mainly on the iol body, multiple light scattering artifacts (spots) can be observed, these spots are of variable diameter, the diameter cannot be determined accurately.In addition it is observed a whitening of the capsulorhexis remnant.The product investigation could not identify a root cause for the reported issue.Although a definitive conclusion cannot be determined based solely on static pictures, the observations may be compatible with glistenings and/or inflammatory cells deposits on iol surfaces, and anterior capsule opacification.There have been no other complaints reported in the lot number.Additional information has been requested.(b)(4).
 
Event Description
An ophthalmologist reported that approximately two months following an intraocular lens (iol) implant procedure, white dots were confirmed on the surface of the iol.Additional information has been requested.Additional information was provided that the patient fully recovered with steroid and antibiotic eye drops.The patient had experienced decreased visual acuity.A yag was applied to the iol surface unlike normal.There are two medical device reports associated with this patient.A previous report 1119421-2018-00666 had been filed for the fellow eye.
 
Manufacturer Narrative
This supplement is being filed to correct the value to adverse event and product problem.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ TORIC SINGLEPIECE IOL
Type of Device
LENS, INTRAOCULAR, TORIC OPTICS
Manufacturer (Section D)
ALCON RESEARCH, LTD. - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LTD. - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
bryan blake
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8176152230
MDR Report Key7658491
MDR Text Key113019969
Report Number1119421-2018-00849
Device Sequence Number1
Product Code MJP
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P930014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Home Health Aide
Type of Report Initial,Followup
Report Date 11/12/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/03/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2020
Device Model NumberSN6AT3
Device Catalogue NumberSN6AT3Q210
Device Lot Number12370589
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/29/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/30/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age72 YR
-
-